Run the List cover image

Overview of Obesity

Run the List

00:00

GLP-1s and newer co-agonists' efficacy

Brooke describes semaglutide, liraglutide, and tirzepatide and expected 10–20% or greater weight loss.

Play episode from 10:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app